Verastem (VSTM)
(Delayed Data from NSDQ)
$3.36 USD
+0.38 (12.75%)
Updated Jul 12, 2024 04:00 PM ET
After-Market: $3.40 +0.04 (1.19%) 7:58 PM ET
4-Sell of 5 4
F Value F Growth A Momentum F VGM
Brokerage Reports
Verastem, Inc. [VSTM]
Reports for Purchase
Showing records 1 - 20 ( 266 total )
Company: Verastem, Inc.
Industry: Medical - Biomedical and Genetics
Promising Early Pancreatic Results Despite Toxicity Concerns; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: LEE S
Company: Verastem, Inc.
Industry: Medical - Biomedical and Genetics
LGSOC Topline Results and NDA Submission Expected in Q2; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: LEE S
Company: Verastem, Inc.
Industry: Medical - Biomedical and Genetics
Eyes on LGSOC NDA Submission and Program Updates; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: LEE S
Company: Verastem, Inc.
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for VSTM 21224
Provider: Stock Traders Daily
Analyst: Research Department
Company: Verastem, Inc.
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for VSTM 12224
Provider: Stock Traders Daily
Analyst: Research Department
Company: Verastem, Inc.
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for VSTM 1224
Provider: Stock Traders Daily
Analyst: Research Department
Company: Verastem, Inc.
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for VSTM 12223
Provider: Stock Traders Daily
Analyst: Research Department
Company: Verastem, Inc.
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for VSTM 112223
Provider: Stock Traders Daily
Analyst: Research Department
Company: Verastem, Inc.
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for VSTM 111123
Provider: Stock Traders Daily
Analyst: Research Department
Company: Verastem, Inc.
Industry: Medical - Biomedical and Genetics
LGSOC NDA Submission Expected in 1H24; Phase 3 Ready to Start; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: LEE S
Company: Verastem, Inc.
Industry: Medical - Biomedical and Genetics
RAMP 201 Study Update at IGCS 2023 Conference; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: LEE S
Company: Verastem, Inc.
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for VSTM 11123
Provider: Stock Traders Daily
Analyst: Research Department
Company: Verastem, Inc.
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for VSTM 102123
Provider: Stock Traders Daily
Analyst: Research Department
Company: Verastem, Inc.
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for VSTM 101123
Provider: Stock Traders Daily
Analyst: Research Department
Company: Verastem, Inc.
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for VSTM 10123
Provider: Stock Traders Daily
Analyst: Research Department
Company: Verastem, Inc.
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for VSTM 92123
Provider: Stock Traders Daily
Analyst: Research Department
Company: Verastem, Inc.
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for VSTM 91123
Provider: Stock Traders Daily
Analyst: Research Department
Company: Verastem, Inc.
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for VSTM 9123
Provider: Stock Traders Daily
Analyst: Research Department
Company: Verastem, Inc.
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for VSTM 82123
Provider: Stock Traders Daily
Analyst: Research Department
Company: Verastem, Inc.
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for VSTM 81123
Provider: Stock Traders Daily
Analyst: Research Department